Cochrane Review: Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder

Zusammenfassung

Selektive Serotonin‐Wiederaufnahmehemmer bei prämenstruellem Syndrom und prämenstrueller dysphorischer Störung - Jespersen, C - 2024 \| Cochrane Library [Skip to Content](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001396.pub4/full/de#main-content) [Close cookies message](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001396.pub4/full/de#) Cookies Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, in

Kerninformationen

396.pub4/full/de#) [Cochrane Database of Systematic reviews](https://www.cochranelibrary.com/en/about/about-cochrane-reviews) Review - Intervention - [New search](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001396.pub4/information/de#history) Collapse all Expand all ## Abstract ...

her administered in the luteal phase or continuously. We undertook a systematic review to assess the evidence of the positive effects and the harms of SSRIs in the management of PMS and PMDD. ### Objectives To evaluate the benefits and harms of SSRIs in treating women diagnosed with PMS and PMDD. ...

PMS, PMDD or LLPDD were randomised to receive SSRIs or placebo. ### Data collection and analysis We used standard Cochrane methods. We pooled data using a random‐effects model. We calculated standardised mean differences (SMDs) with 95% confidence intervals (CIs) for premenstrual symptom scores, u...

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen